These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 4562819)
1. Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future. Lester W Annu Rev Microbiol; 1972; 26():85-102. PubMed ID: 4562819 [No Abstract] [Full Text] [Related]
2. Chemical and biological properties of rifampicin. Furesz S Antibiot Chemother; 1970; 16():316-51. PubMed ID: 5002304 [No Abstract] [Full Text] [Related]
7. Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin. Riva S; Fietta A; Silvestri LG Biochem Biophys Res Commun; 1972 Dec; 49(5):1263-71. PubMed ID: 4566674 [No Abstract] [Full Text] [Related]
8. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV]. Grumbach F; Rist N Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378 [No Abstract] [Full Text] [Related]
9. CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria. Wehrli W; Zimmermann W; Kump W; Tosch W; Vischer W; Zak O J Antibiot (Tokyo); 1987 Dec; 40(12):1733-9. PubMed ID: 2448280 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules. Mosaei H; Zenkin N EcoSal Plus; 2020 Apr; 9(1):. PubMed ID: 32342856 [TBL] [Abstract][Full Text] [Related]
18. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Matsuoka M; Kashiwabara Y; Namisato M Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288 [TBL] [Abstract][Full Text] [Related]
19. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive. Rouzaud F; Robledo J Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587 [No Abstract] [Full Text] [Related]